scholarly journals Ketogenic Diet as Medical Nutrition Therapy

2019 ◽  
Vol 7 (02) ◽  
pp. 73-76
Author(s):  
Dharini Krishnan ◽  
Chetan Mehndiratta ◽  
Tanmay Agrawal

AbstractMedical nutrition therapy is a therapeutic approach to treat medical conditions and their associated symptoms via using a specifically tailored diet devised under the supervision of a doctor and a registered dietitian or nutrition professional. Ketogenic diet primarily consists of the high amount of fats, a moderate amount of proteins, and very low carbohydrates. It is known to stimulate the metabolic effects of starvation by forcing the body to use primarily fat as a fuel source. Ketogenic diet was developed in the 1920s. Nowadays, it is gaining considerable attention as a potential weight-loss strategy because of the low-carb diet. However, it is being considered for use in several diseases/disorders also because of the beneficial effects on the metabolic health and nervous system. This review revisits the therapeutic potential of ketogenic diets in many pathological conditions and its role as a medical nutrition therapy. It also talks about the ill effects that the keto diet can have in case of self-usage and monitoring.

2021 ◽  
Vol 9 (2) ◽  
pp. 564-569
Author(s):  
Dr Vishal D. Sawant ◽  
Dr Varun Viswanathan ◽  
Dr Alka Jadhav ◽  
Dr Madhubala Jadhav ◽  
Dr Swathi Krishna ◽  
...  

The term malnutrition involves both over nutrition, accompanying with overweight, obesity, and under-nutrition including acute and chronic malnutrition as well as micronutrient deficiencies. The present study was undertaken to assess clinical outcome at 8 weeks and 6 months in children with Severe Thinness on Medical Nutrition Therapy (MNT). A total of 52 severe thinness (ST) children were enrolled and given MNT. The anthropometry was recorded at every visit and analyzed at two time points viz.8 weeks and 6 months. The body mass index has been measured using formula: weight (kg)/height(metre)2. Mean weight on enrolment was 15.85±4.08 kg. At 8 weeks, mean weight was 17.35±4.55 kg and at 6 months it was 19.33±5.12 kg. Mean height on enrolment was 114.33±14.06 cm while at 8 weeks was 115.27±14.06 cm and at 6 months was 120.21±15.29 cm. Mean BMI on enrolment was 11.92±0.44kg/m2 while at 8 weeks it improved to 12.89±0.67kg/m2; at 6 months, it continued improved to 13.26±0.96kg/m2. Rate of weight gain from enrolment to 8 weeks was 1.67 grams/kg/day and from 8 weeks to 6 months was 0.36 gm/kg/day (P<0.001). At end of 8 weeks, in 73.33% subjects BMI improved to thin and 17.8% became normal while 8.9 % continued to remain ST. At 6 months, 22.22% remained ST, 33.33% subjects remained thin and 44.44% became normal. Improvement in mean weight and mean BMI as well as rate of weight gain was significant indicating the role of indigenously prepared MNT in improving acute malnutrition.


Nutrients ◽  
2021 ◽  
Vol 14 (1) ◽  
pp. 191
Author(s):  
Ilias Attaye ◽  
Sophie van Oppenraaij ◽  
Moritz V. Warmbrunn ◽  
Max Nieuwdorp

The ketogenic diet is a dietary regime focused on strongly reducing carbohydrate intake and increasing fat intake; leading to a state of ketosis. The ketogenic diet has gained much popularity over the years due to its effects on promoting weight loss, increasing insulin sensitivity and reducing dyslipidaemia. All these factors play a crucial role in the development of cardio-metabolic diseases; one of the greatest health challenges of the time. Moreover, the ketogenic diet has been known to reduce (epileptic) seizure activity. It is still poorly understood how following a ketogenic diet can lead to these beneficial metabolic effects. However, in recent years it has become clear that diet and the gut microbiota interact with one another and thus influence host health. The goal of this review is to summarize the current state of knowledge regarding the beneficial metabolic effects of the ketogenic diet and the role of gut microbiota in these effects.


Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 280-OR
Author(s):  
KATHERINE A. SAUDER ◽  
JEANETTE M. STAFFORD ◽  
NATALIE S. THE ◽  
ELIZABETH J. MAYER-DAVIS ◽  
JOAN THOMAS ◽  
...  

Author(s):  
Nina Meloncelli ◽  
Shelley A. Wilkinson ◽  
Susan de Jersey

AbstractGestational diabetes mellitus (GDM) is a common pregnancy disorder and the incidence is increasing worldwide. GDM is associated with adverse maternal outcomes which may be reduced with proper management. Lifestyle modification in the form of medical nutrition therapy and physical activity, as well as self-monitoring of blood glucose levels, is the cornerstone of GDM management. Inevitably, the search for the “ultimate” diet prescription has been ongoing. Identifying the amount and type of carbohydrate to maintain blood glucose levels below targets while balancing the nutritional requirements of pregnancy and achieving gestational weight gain within recommendations is challenging. Recent developments in the area of the gut microbiota and its impact on glycemic response add another layer of complexity to the success of medical nutrition therapy. This review critically explores the challenges to dietary prescription for GDM and why utopia may never be found.


2017 ◽  
Vol 27 (2) ◽  
pp. e11-e14 ◽  
Author(s):  
Jennifer Carvalho-Salemi ◽  
Lorrie Moreno ◽  
Mini Michael

Endocrinology ◽  
2021 ◽  
Author(s):  
Katharina Schnabl ◽  
Yongguo Li ◽  
Mueez U-Din ◽  
Martin Klingenspor

Abstract The obesity pandemic requires effective preventative and therapeutic intervention strategies. Successful and sustained obesity treatment is currently limited to bariatric surgery. Modulating the release of gut hormones is considered promising to mimic bariatric surgery with its beneficial effects on food intake, body weight and blood glucose levels. The gut peptide secretin was the first molecule to be termed a hormone; nevertheless, it only recently has been established as a legitimate anorexigenic peptide. In contrast to gut hormones that crosstalk with the brain either directly or by afferent neuronal projections, secretin mediates meal-associated brown fat thermogenesis to induce meal termination, thereby qualifying this physiological mechanism as an attractive, peripheral target for the treatment of obesity. In this perspective, it is of pivotal interest to deepen our yet superficial knowledge on the physiological roles of secretin as well as meal-associated thermogenesis in energy balance and body weight regulation. Of note, the emerging differences between meal-associated thermogenesis and cold-induced thermogenesis must be taken into account. In fact, there is no correlation between these two entities. In addition, the investigation of potential effects of secretin in hedonic-driven food intake, bariatric surgery as well as chronic treatment using suitable application strategies to overcome pharmacokinetic limitations will provide further insight into its potential to influence energy balance. The aim of this article is to review the facts on secretin’s metabolic effects, address prevailing gaps in our knowledge, and provide an overview on the opportunities and challenges of the therapeutic potential of secretin in body weight control.


2018 ◽  
Vol 6 (1) ◽  
pp. e000550 ◽  
Author(s):  
Carla Assaf-Balut ◽  
Nuria Garcia de la Torre ◽  
Alejandra Durán ◽  
Manuel Fuentes ◽  
Elena Bordiú ◽  
...  

ObjectivesTo assess whether Mediterranean Diet (MedDiet)-based medical nutrition therapy facilitates near-normoglycemia in women with gestational diabetes mellitus (GDMw) and observe the effects on adverse pregnancy outcomes.Research design and methodsThis is a secondary analysis of the St Carlos GDM Prevention Study, conducted between January and December 2015 in Hospital Clínico San Carlos (Madrid, Spain). One thousand consecutive women with normoglycemia were included before 12 gestational weeks (GWs), with 874 included in the final analysis. Of these, 177 women were diagnosed with gestational diabetes mellitus (GDM) and 697 had normal glucose tolerance. All GDMw received MedDiet-based medical nutrition therapy with a recommended daily extra virgin olive oil intake ≥40 mL and a daily handful of nuts. The primary goal was comparison of hemoglobin A1c (HbA1c) levels at 36–38 GWs in GDMw and women with normal glucose tolerance (NGTw).ResultsGDMw as compared with NGTw had higher HbA1c levels at 24–28 GWs (5.1%±0.3% (32±0.9 mmol/mol) vs 4.9%±0.3% (30±0.9 mmol/mol), p=0.001). At 36–38 GWs values were similar between the groups. Similarly, fasting serum insulin and homeostatic model assessment insulin resitance (HOMA-IR) were higher in GDMw at 24–28 GWs (p=0.001) but became similar at 36–38 GWs. 26.6% of GDMw required insulin for glycemic control. GDMw compared with NGTw had higher rates of insufficient weight gain (39.5% vs 22.0%, p=0.001), small for gestational age (6.8% vs 2.6%, p=0.009), and neonatal intensive care unit admission (5.6% vs 1.7%, p=0.006). The rates of macrosomia, large for gestational age, pregnancy-induced hypertensive disorders, prematurity and cesarean sections were comparable with NGTw.ConclusionsUsing a MedDiet-based medical nutrition therapy as part of GDM management is associated with achievement of near-normoglycemia, subsequently making most pregnancy outcomes similar to those of NGTw.


2017 ◽  
Vol 27 (3) ◽  
pp. 281-285 ◽  
Author(s):  
Daniel Pieloch ◽  
Golnaz G. Friedman ◽  
Sara DiCecco ◽  
Linda Ulerich ◽  
Stacey Beer ◽  
...  

Dietitians have extensive training and are considered the experts in medical nutrition therapy (MNT). Although dietitian competencies for MNT are well established, competencies that account for the expanded roles of dietitians working in transplantation have not been developed. These expanded roles require a better understanding of transplant processes, regulations, and even the business side of transplant, novel concepts to most dietitians. Therefore, we proposed a standardized framework of transplant-specific competencies for dietitians practicing in transplantation. These competencies can help improve and standardize initial and ongoing training for transplant dietitians moving forward, ultimately leading to improved patient care for transplant candidates, recipients, and donors.


Sign in / Sign up

Export Citation Format

Share Document